AerSale Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AerSale Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $335.29M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $345.07M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $334.50M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $408.54M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $340.44M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $208.94M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $304.20M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $290.73M | Mar 16, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $335.29M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $345.07M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $334.50M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $408.54M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $340.44M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $208.94M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $304.20M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $290.73M | Mar 16, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.77M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $103.94M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $92.42M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $151.39M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $119.39M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $52.79M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $85.05M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $72.17M | Mar 16, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.58M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $5.85M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | ($5.56M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $43.86M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $36.12M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $8.09M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $15.50M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | ($451) | Mar 2, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.79M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $9.74M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | ($10.77M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $55.05M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $56.66M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $11.28M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $22.06M | Mar 15, 2022 |
| FY2019 | Dec 31, 2018 | ($451) | Mar 2, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $89.98M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $94.19M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $103.19M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $96.35M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $77.50M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $55.64M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $59.81M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $46.61M | Mar 16, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($22.97M) | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $11.18M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | ($174.15M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | ($113.0K) | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $79.08M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | ($12.23M) | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $45.46M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $59.25M | Mar 16, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.08M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $14.05M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $11.36M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $8.46M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $1.51M | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | $2.14M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $1.65M | Mar 15, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $640.47M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $604.72M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $553.94M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $531.58M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $487.49M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $389.13M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $343.98M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $417.5K | Mar 2, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $216.04M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $149.10M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $108.92M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $86.60M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $78.61M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $37.67M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $50.00M | Mar 16, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $5.00M | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | $24.5K | Mar 2, 2020 |
| FY2019 | Aug 19, 2018 | $0 | Mar 2, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.86M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $19.86M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $19.86M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $19.86M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $19.86M | Mar 7, 2023 |
| FY2022 | Dec 31, 2020 | $19.86M | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | $13.86M | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | $442.0K | Mar 16, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $147.70M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $139.12M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $133.27M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $138.83M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $94.97M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $58.86M | Mar 15, 2022 |
| FY2021 | Dec 22, 2020 | $400.0K | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $50.76M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($451) | Mar 2, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.38M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.70M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $5.87M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $147.19M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | $130.19M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $29.32M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $17.51M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $41.1K | Mar 2, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.28M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.21M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $7.28M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $0 | Mar 7, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $3.35M | Mar 16, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | 7 | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | (516) | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | (668) | Mar 16, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 8, 2024 |
| FY2022 | Dec 31, 2020 | 7 | Mar 7, 2023 |
| FY2021 | Dec 31, 2019 | (516) | Mar 15, 2022 |
| FY2020 | Dec 31, 2018 | (668) | Mar 16, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47.22M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 53.25M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | 52.95M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 51.19M | Mar 8, 2024 |
| FY2022 | Dec 31, 2021 | 51.67M | Mar 7, 2023 |
| FY2021 | Dec 31, 2020 | 41.05M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | 5.29M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | 4.31M | Mar 2, 2020 |